Category Archives: SSRI Antidepressants

Featured Stories

Smith & Nephew Recalls Metal-on-Metal Hip Implant Component

Medical device maker, Smith & Nephew, just issued a recall for a metal-on-metal hip implant component, a part of one of its all-metal hip replacement systems.

Read More

Actos Whistleblower Lawsuit Questions Avandia Researcher's Financial Ties to Takeda

A prominent researcher has been implicated in an alleged cover-up of Actos side effects, according to a report from TheHeart.org. An Actos whistleblower lawsuit unsealed earlier this year has alleged financial connections between the Cleveland Clinic’s Dr Steven Nissen and the maker of Actos “should be considered when analyzing Actos’s ...

Read More

What Action Will the FDA Take on E-cigarettes?

What Action Will the FDA Take on E-cigarettes?

As health and quality concerns trouble the e-cigarette industry, experts and the public await the Food and Drug Administration (FDA)’s action to regulate the devices.

Read More

FDA Urged to Ban Powdered Caffeine

FDA Urged to Ban Powdered Caffeine

Pennsylvania Senator Robert Casey has written to the Food and Drug Administration (FDA) to urge the agency to ban powdered caffeine, a dietary supplement.

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

Study Suggests Hormonal Contraceptives Linked to Brain Tumor

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.

Read More

FDA Warning for Bone Graft Products in Patients Under 18

FDA Safety Warning for Bone Graft Products in Patients Under 18

FDA issued safety alerts to patients, parents & guardians, bone graft devices w/recombinant proteins or synthetic peptides not to be the first treatment for 18 & under.

Read More

Pradaxa not Fit for a Dog, Family of Alleged Pradaxa Bleeding Victim Claims

The family of a Texas woman who died just months before her 60th wedding anniversary believes she would be alive today were it not for Pradaxa (dabigatran). According to a report from the Houston Press, Pradaxa patient Loraine Franklin fell and hit her head last December, resulting in an intracranial ...

Read More

Tennessee Resident Files Pradaxa Bleeding Lawsuit Following Cerebral Hemorrhage

A man from Tennessee has filed a lawsuit against the maker of Pradaxa, claiming that the blood thinner caused him to suffer a cerebral hemorrhage. The complaint alleges Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause Serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects ...

Read More

SSRI Antidepressants Can Increase Patient’s Fear and Anxiety

SSRI Antidepressants Can Increase Patient’s Fear and Anxiety

For some of the millions of people worldwide who take selective serotonin re-uptake inhibitors (SSRIs) to treat depression, the drug may actually increase the patient’s fear and anxiety. This family of widely prescribed drugs includes Prozac (fluoxetine) and Zoloft (sertraline). … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants | Tagged , , , , , , , , , , , , , |

Forest Laboratories Denies Claims in Antidepressant Drug Multidistrict Litigation

  Forest Laboratories is facing claims in a multidistrict litigation (MDL) that alleges it misrepresented the efficacy of the antidepressant drugs Lexapro and Celexa for the treatment of depression in pediatric patients. Forest countered telling the Massachusetts federal court that … Continue reading

Posted in Consumer Fraud, Health Concerns, Pharmaceuticals, SSRI Antidepressants |

New Study Warns of Increased Bleeding Risk In Patients with Combined Use of Antidepressants and NSAIDs

Combining Antidepressants & NSAIDs Cause Bleeding Risks

Results of a new study from a research team in Korea indicate that the combined use of antidepressants and nonsteroidal anti-inflammatory drugs (NSAIDs), a common form of painkiller, is associated with an increased risk of intracranial bleeding. The authors write … Continue reading

Posted in Health Concerns, Pharmaceuticals, SSRI Antidepressants | Tagged , , , , |

Following Husband’s Death, Widow’s Sues Over Allegedly Weak Warning Label on Generic Medication

A widow is suing the maker of  (paroxetine) tablets that her husband, 42 at the time of his death, took as prescribed in 2010. The widow alleges that just six paroxetine tablets led to her husband’s suicide and did not … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

SSRI Antidepressant Use in Pregnancy Tied to Autism Risk

A new study reports that boys with autism were three times more likely to have been exposed to SSRI antidepressants (selective serotonin reuptake inhibitors)  in the womb than typically developing children. Boys whose mothers took SSRIs – including Celexa (citalopram), … Continue reading

Posted in Health Concerns, Pharmaceuticals, SSRI Antidepressants |

Maternal Use of SSRI Antidepressants Linked to Pulmonary Hypertension in Newborns

ssri-antidepressants-newborn-hypertension

New research shows that maternal use of SSRI antidepressants late in pregnancy is linked to increased risk for persistent pulmonary hypertension (PPH) in newborns. A meta-analysis of seven studies shows a significant association between PPH – increased pressure in the pulmonary arteries – in infants whose … Continue reading

Posted in Health Concerns, Pharmaceuticals, SSRI Antidepressants |

Adipotrim XT Dietary Supplement Recalled for Undeclared Drug Ingredient

adipotrim-xt-supplement-recall

Deseo Rebajar Inc., is voluntarily recalling Adipotrim XT, a dietary supplement sold directly to customers in Fajardo, Caguas and Bayamon, Puerto Rico, and online. A U.S. Food and Drug Administration (FDA) laboratory analysis found it to contain undeclared fluoxetine, a selective … Continue reading

Posted in Health Concerns, Pharmaceuticals, Product Recalls, SSRI Antidepressants |

Study: SSRIs Use Tied to Upper GI Bleeds

ssri_tied_to_gi_tract_bleeding

The use of selective serotonin reuptake inhibitors (SSRIs) for as little as seven days presents significant increased risks for upper gastrointestinal (GI) bleeding events, according to a new study. “Consistent with previous studies, SSRIs were the only antidepressants found to … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

Study: Certain Antidepressants Linked to Increased Clostridium Difficile Risks

antidepressants-Clostridium-difficile-infections

The antidepressants mirtazapine—sold under the brands Remeron, Avanza, and Zispin—and fluoxetine (known as Prozac, Sarafem, or Fontex) have been associated with an increased risk Clostridium difficile infection (CDI), according to new research. Investigators at the University of Michigan in Ann … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

JAMA Study: Perioperative SSRI Use Associated with Increased Adverse Event Risks

SSRI-Adverse_Effects

A new study found that patients taking selective serotonin reuptake inhibitors (SSRIs) during the perioperative period (from hospitalization admission to discharge) were at increased risks for suffering an adverse event. The study appears in the April 29, 2013 issue of … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.